Search hospitals > Rhode Island > Providence
Rhode Island Hospital
Claim this profileProvidence, Rhode Island 02903
Global Leader in Leukemia
Global Leader in Cancer
Conducts research for Tumors
Conducts research for Lymphoma
Conducts research for Breast Cancer
856 reported clinical trials
61 medical researchers
Summary
Rhode Island Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Leukemia, Cancer, Tumors, Lymphoma, Breast Cancer and other specialties. Rhode Island Hospital is involved with conducting 856 clinical trials across 963 conditions. There are 61 research doctors associated with this hospital, such as Jennifer J. Welch, Benedito Carneiro, Adam J. Olszewski, and Eric Wong, MD.Area of expertise
1Leukemia
Global LeaderPhiladelphia chromosome positive
NTRK1 positive
NTRK positive
2Cancer
Global LeaderStage IV
Stage I
Stage II
Top PIs
Jennifer J. WelchRhode Island Hospital6 years of reported clinical research
Expert in Tumors
Expert in Leukemia
45 reported clinical trials
107 drugs studied
Benedito CarneiroRhode Island Hospital1 year of reported clinical research
Studies Solid Tumors
Studies Tumors
11 reported clinical trials
21 drugs studied
Adam J. OlszewskiRhode Island Hospital2 years of reported clinical research
Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
10 reported clinical trials
25 drugs studied
Eric Wong, MDBeth Israel Deaconess Medical Center1 year of reported clinical research
Studies Cancer
Studies Brain Tumor
8 reported clinical trials
15 drugs studied
Clinical Trials running at Rhode Island Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Lymphoma
Tumors
Rhabdomyosarcoma
Squamous Cell Carcinoma
Cancer
Prostate Cancer
Leukemia
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
The primary objective of this study is to compare the progression-free survival (PFS) between sacituzumab govitecan-hziy (SG) and pembrolizumab versus treatment of physician's choice (TPC) and pembrolizumab in participants with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors express programmed cell death ligand 1 (PD-L1).
Recruiting4 awards Phase 3
Imlunestrant
for Early Breast Cancer
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have already taken endocrine therapy for two to five years and must have a higher-than-average risk for their cancer to return. Study participation could last up to 10 years.
Recruiting2 awards Phase 36 criteria
Support Program
for Breast Cancer
This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rhode Island Hospital?
Rhode Island Hospital is a medical facility located in Providence, Rhode Island. This center is recognized for care of Leukemia, Cancer, Tumors, Lymphoma, Breast Cancer and other specialties. Rhode Island Hospital is involved with conducting 856 clinical trials across 963 conditions. There are 61 research doctors associated with this hospital, such as Jennifer J. Welch, Benedito Carneiro, Adam J. Olszewski, and Eric Wong, MD.
Where is Rhode Island Hospital located?
To reach Rhode Island Hospital in Providence, RI, take exit 20 from I-95 North and follow signs for Point Street. Turn left onto Friendship Street at the end of the ramp, then continue straight to 593 Eddy Street. Alternatively, GPS navigation services like MapQuest or Waze can provide real-time driving directions.
Who should I call to ask about financial aid or insurance network?
**Rhode Island Hospital Financial Assistance:**
- For financial assistance, contact the Patient Financial Advocacy Program at (401) 788-1383. Assistance is available for uninsured Rhode Island residents meeting income criteria.
- The Charity Care program aids uninsured, low-income residents who cannot access state, federal, or employer-sponsored health insurance.
**Insurance Inquiries:**
- For insurance questions or help understanding hospital bills, call customer service at 1-800-884-6966.
What insurance does Rhode Island Hospital accept?
Rhode Island Hospital accepts a wide range of insurance plans, including but not limited to Aetna, Blue Cross Blue Shield of Rhode Island, Harvard Pilgrim Health Care, and United HealthCare. Note that fees for personal physicians, specialists, and private duty nurses might not be included in the hospital's billing. Island Health also accepts various insurances, such as Aetna, Cigna, Kaiser Permanente, Medicare, and United Healthcare.
What awards or recognition has Rhode Island Hospital received?
Rhode Island Hospital, located in Providence, Rhode Island, is a distinguished facility recognized for its excellence in research and care. It has been named a Blue Distinction Center for both Cancer Care and Cardiac Care by the Blue Cross Blue Shield Association. The hospital is also notable for ranking 13th among independent hospitals in National Institutes of Health funding, receiving over $27 million annually, and has earned the Get With The Guidelines-Stroke Gold Plus award from the American Heart Association/American Stroke Association, including honors in Stroke Elite Plus, Stroke Advanced Therapy, and Type 2 Diabetes.